Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

RainDog

(28,784 posts)
11. Cannabis-derived medication gets "orphan drug" approval by FDA
Sun Jun 15, 2014, 02:00 PM
Jun 2014

again, after Dr. Sanjay Gupta talked about the FDA's lying lies.

http://www.epilepsyresearch.org.uk/cannabis-derived-dravet-syndrome-drug-gets-us-orphan-drug-approval/

Epidiolex, a medicine that uses cannabidiol (CBD) as an active ingredient, has been designated an orphan drug for Dravet syndrome by the US Food and Drug Administration, giving manufacturer GW Pharmaceuticals the go-ahead to run a clinical development programme next year.

CBD is a non-psychoactive compound derived from the cannabis plant. In GW Pharmaceuticals’ formulation, it is administered orally, as a liquid.

The orphan drug designation means it is recognised as a potential therapy for a condition that only affects a small number of people – in this case a rare form of paediatric epilepsy.

...GW Pharmaceuticals expects to begin a formal clinical development programme for Epidiolex in 2014. In the meantime, some US paediatric epilepsy specialists will be able to treat patients with the drug immediately thanks to seven Investigational New Drug (IND) applications granted to the firm by the FDA.

Recommendations

0 members have recommended this reply (displayed in chronological order):

Latest Discussions»Issue Forums»Drug Policy»The BULLSHITTERS are layi...»Reply #11